InvestorsHub Logo

nidan7500

10/09/18 10:55 AM

#168087 RE: XenaLives #168084

I found it odd that the Cantor guy introducing Missling at the recent presentation said he didn't know much about the stock.


Completely agree w/this observation. If he did that w/BIIB he would be cleaning out his desk before the day was over. It was an IN YOUR FACE DIS.

We should expect BIIB to be as vocal and over the top as they need to be to dominate the PR cycle leading to CTAD. If we are anywhere near as good as we claim to be we need to conduct a massive (unscientific like) bells and whistles campaign NOW. Yes, I know it is expensive and the BIIB people already have everyone's dance cards but THIS IS NOT OPTIONAL. AVXL MUST EXECUTE.

dia76ca

10/09/18 11:12 AM

#168090 RE: XenaLives #168084

I agree that it was a very odd introduction. I think a Cantor report following CTAD would be very well timed. The contrast between Biogen and Anavex will be clear to all. And it is great to have Dr.Hampel on our side!

kevindenver

10/09/18 11:24 AM

#168092 RE: XenaLives #168084

Listen again, that is NOT what Cantor said.

He said: "I don't CURRENTLY cover Anavex, so I can not make an investment recommendation"

He did not state "he didn't know much about the stock."

A subtle but possibly key difference.